APRINOIA Therapeutics

About:

Biotechnology, Neuorscience

Website: http://www.aprinoia.com/

Top Investors: IMM Investment, Alzheimer's Drug Discovery Foundation, Company K Partners, KTB Network, DCI Partners

Description:

APRINOIA is a late-stage biotechnology company committed to protecting patients' brain health and changing outcomes of neurodegenerative diseases through first-in-class and best-in-class diagnostic tools and novel therapies. The company aims to bring precision medicine to neuroscience by identifying and targeting the protein aggregates of tau, alpha-synuclein and other proteins that play a critical role in the pathogenesis of many neurodegenerative diseases, such as Alzheimer's and Parkinson's Diseases. The company currently has operations in Hong Kong, Suzhou, Shanghai, Tokyo, and Boston.